Aim Immunotech shares owned by Morgan Stanley
Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Aim Immunotech
Tip: Access up to 7 years of quarterly data
All positions including Aim Immunotech held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aim Immunotech by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $40k | 85k | 0.47 |
| 2023-09-30 | $115k | 252k | 0.46 |
| 2023-06-30 | $292k | 436k | 0.67 |
| 2022-12-31 | $286k | 917k | 0.31 |
| 2022-06-30 | $1.2M | 1.6M | 0.78 |
| 2022-03-31 | $2.1M | 2.0M | 1.06 |
| 2021-06-30 | $5.4M | 2.5M | 2.15 |
| 2020-12-31 | $1.8M | 999k | 1.79 |
| 2020-09-30 | $1.7M | 805k | 2.15 |
| 2020-06-30 | $1.2M | 476k | 2.48 |
| 2020-03-31 | $46k | 18k | 2.53 |
| 2019-12-31 | $0 | 76 | 0.00 |
| 2019-09-30 | $109k | 144k | 0.76 |